Ozempic Lawsuit Update: Claims and Payout Status (2026)

Last updated: July 2026

The Ozempic lawsuit is active federal litigation against Novo Nordisk and Eli Lilly over stomach paralysis, bowel injuries, and sudden vision loss linked to GLP-1 drugs. As of July 2026, more than 3,800 cases are pending in the main federal docket, no settlements have been reached, and a major expert hearing is set for September 2026.

If you or a family member took Ozempic, Wegovy, Mounjaro, or a similar drug and got seriously hurt, this guide explains where the litigation stands right now. It covers the injuries involved, the key court rulings so far, and what has to happen before anyone sees compensation.

Why Are People Suing Over Ozempic?

Plaintiffs say the drug makers failed to warn patients and doctors about the risk of severe, sometimes permanent injuries. The core legal theory is failure to warn, not that the drugs never should have been sold.

The cases target GLP-1 receptor agonists, a class of drugs originally approved for type 2 diabetes and later used widely for weight loss. Millions of Americans have taken them, which is why this litigation grew so fast.

What Injuries Are Part of the Claims?

Two groups of injuries dominate the litigation.

Stomach and bowel injuries

The largest group involves gastroparesis, often called stomach paralysis. The stomach stops emptying normally, which can cause relentless vomiting, malnutrition, hospital stays, and in severe cases a feeding tube. Related claims include ileus, intestinal blockage, and bowel injuries.

In August 2025, the judge ruled that gastroparesis claims must be backed by objective medical testing, such as a gastric emptying study. Symptoms alone are not enough to keep a case in the litigation.

Sudden vision loss (NAION)

A newer wave of cases involves NAION, short for non-arteritic anterior ischemic optic neuropathy. It is a stroke-like event in the optic nerve that can cause sudden, permanent vision loss in one or both eyes. A 2024 study in JAMA Ophthalmology reported notably higher NAION rates among semaglutide users, and later research has continued to examine the link. In 2025, European and US regulators moved to have NAION addressed in semaglutide product information. [VERIFY current label status]

Where Does the Ozempic Lawsuit Stand in July 2026?

There are now two separate federal consolidated dockets, both in the Eastern District of Pennsylvania before Judge Karen S. Marston.

MDL 3094 covers the stomach and bowel injury cases. It was created in February 2024 and held 3,848 pending cases as of July 1, 2026, with new filings added every month. MDL 3163 covers the vision loss cases. It was formed in December 2025 and is still small, with roughly 100 federal cases so far. [VERIFY current MDL 3163 case count]

Two rulings and one upcoming event matter most. First, the August 15, 2025 ruling on the motion to dismiss trimmed some claims, including design defect theories, but let the core failure-to-warn claims move forward. Second, the objective-testing requirement for gastroparesis raised the proof bar for every plaintiff. Third, the court has reserved September 10-18, 2026 for a Rule 702 hearing on expert testimony. That hearing will decide whether the plaintiffs’ scientific experts can testify about general causation. It is the single biggest pressure point in the entire Ozempic lawsuit right now.

Has Anyone Received Compensation Yet?

No. As of July 2026 there have been no trials, no verdicts, and no global settlement in either MDL. That is normal at this stage. Large drug litigations usually take three to six years from consolidation to the first settlements, and this one is in the expert-challenge phase.

Some law firms publish projected settlement ranges. Treat these as marketing estimates, not promises. They vary widely by source and nothing has been paid out. [VERIFY figures against current filings]

Real values, if settlements come, will depend on the Rule 702 outcome, bellwether trial results, the strength of each person’s medical records, and how long they used the drug.

Who Can File a Claim?

Every firm sets its own criteria, but most accepted cases share these elements:

• You took Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, or Trulicity, with records proving it.
• You were diagnosed with gastroparesis (usually confirmed by a gastric emptying study), a bowel obstruction, ileus, or NAION.
• Your symptoms were serious: think hospitalization, repeated ER visits, prolonged vomiting, surgery, or documented vision loss.
• You did not have a condition that already explained the injury, such as prior gastric surgery or long-standing severe diabetic gastroparesis.
• You are within your state’s statute of limitations, which is often 1-3 years from the injury or its discovery.

What Should You Do Next?

1. Keep taking or stopping medication only on your doctor’s advice. Never change treatment because of a lawsuit ad.
2. Gather proof of use: pharmacy printouts, prescription records, and insurance statements.
3. Collect medical records, especially any gastric emptying study, imaging, surgical reports, or ophthalmology records.
4. Write down your timeline: when you started the drug, when symptoms began, and every hospital visit.
5. Talk to a mass tort lawyer soon. Consultations are free, fees are contingency-based, and deadlines are strict.

The bottom line: the Ozempic lawsuit is moving, but it has not reached the settlement stage. The September 2026 expert hearing is the next event that could change compensation timelines in a meaningful way. If you were injured, the smart play is to preserve your records and get your claim filed before your state deadline, then let the litigation develop.

Frequently Asked Questions

Is the Ozempic lawsuit a class action?

No. The federal cases are consolidated in multidistrict litigation, or MDL. An MDL pools cases before one judge for pretrial work, but each person files an individual claim and any payout depends on individual injuries. Unlike a class action, you are not included automatically. You must file your own case to be part of any future settlement.

How much could an Ozempic settlement be worth?

No settlements exist yet, so every number you see is a projection. Attorney estimates published in 2026 range from roughly $50,000 for less severe gastroparesis to more than $1 million for permanent vision loss. Actual values will depend on the expert rulings, early trial results, and your medical records. Be skeptical of any firm promising a specific amount.

Is it too late to file an Ozempic claim?

For most people, no. New cases were still being filed in July 2026 and the courts continue to accept them. But every state has a statute of limitations, often 1-3 years from the injury or its discovery. If you miss your state’s deadline you lose the right to sue, so it is worth speaking with a lawyer promptly.

Has anyone won an Ozempic lawsuit yet?

No. As of July 2026, no bellwether trial has been held and no settlement has been announced in either MDL. The litigation is in pretrial proceedings, with a key expert admissibility hearing reserved for September 10-18, 2026. The outcome of that hearing will shape whether the cases move toward trials or narrow sharply.

Do I have to stop taking Ozempic to file a claim?

No court requires you to stop a prescribed medication in order to file. Do not change or stop any drug without talking to your doctor first, because stopping suddenly can affect your blood sugar, weight, and overall health. Your lawyer handles the claim. Your physician handles your treatment. Keep those two decisions separate.

Disclaimer: This article is general information about pending litigation, not legal or medical advice. Court numbers and deadlines change quickly. For advice about your specific situation, talk to a licensed attorney in your state and consult your doctor about any medication decisions.